- The effect of antioxidant supplementation on dysmenorrhea and endometriosis-associated painful symptoms: a systematic review and meta-analysis of randomized clinical trials
-
Baradwan S, Gari A, Sabban H, Alshahrani MS, Khadawardi K, Bukhari IA, Alyousef A, Abu-Zaid A
- KMID: 2553426
- Obstet Gynecol Sci.
- 2024 Mar;67(2):186-198.
- doi: 10.5468/ogs.23210
This study aimed to review randomized controlled trials (RCTs) investigating the effects of dietary antioxidant supplements on the severity of endometriosis-related pain symptoms. The PubMed/Medline, Scopus, and Web of Science... -
- CITED
-
- Close
- SHARE
-
- Close
- Prophylactic tranexamic acid to reduce blood loss and related morbidities during hysterectomy: a systematic review and meta-analysis of randomized controlled trials
-
Abu-Zaid A, Baradwan S, Badghish E, AlSghan R, Ghazi A, Albouq B, Khadawardi K, AlNaim NF, AlNaim LF, Fodaneel M, AbuAlsaud FS, Jamjoom MZ, Almubarki AA, Alsehaimi SO, Alabdrabalamir S, Alomar O, Al-Badawi IA, Salem H
- KMID: 2533814
- Obstet Gynecol Sci.
- 2022 Sep;65(5):406-419.
- doi: 10.5468/ogs.22115
To perform a systematic review and meta-analysis of all randomized controlled trials (RCTs) that evaluated the efficacy and safety of prophylactic tranexamic acid (TXA) versus a control (placebo or no... -
- CITED
-
- Close
- SHARE
-
- Close
- 17-alpha hydroxyprogesterone caproate for the prevention of recurrent preterm birth among singleton pregnant women with a prior history of preterm birth: a systematic review and meta-analysis of six randomized controlled trials
-
Baradwan S, Abdulghani SH, Abuzaid M, Khadawardi K, Alshahrani MS, Al-Matary A, AlRasheed MA, Miski NT, Abdulhalim A, Alturki YM, Abu-Zaid A
- KMID: 2522472
- Obstet Gynecol Sci.
- 2021 Nov;64(6):484-495.
- doi: 10.5468/ogs.21264
To perform a systematic review and meta-analysis of all randomized controlled trials (RCTs) that investigated the clinical benefits of 17-alpha hydroxyprogesterone caproate (17OHPC) in the prevention of recurrent preterm birth... -
- CITED
-
- Close
- SHARE
-
- Close
